At Virofend SL, we develop virus-based therapies, specifically targeting cancer. Viral treatments represent one of the most innovative and promising areas in modern medicine, leveraging the unique properties of viruses, such as their ability to infect specific cells and trigger immune responses. Genetically modified viruses are used to attack and destroy cancer cells. These approaches not only offer new hope for difficult-to-treat diseases but also open the door to an era of personalized and highly effective treatments.
Company Details
- Employees
- 11
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://virofend.com/
- Keywords
- of ViroFend's exciting project..
Virofend Therapeutics S.l. Questions
Virofend Therapeutics S.L.'s website is https://virofend.com/
Virofend Therapeutics S.L.'s LinkedIn profile is https://www.linkedin.com/company/virofend-sl
Virofend Therapeutics S.L. has
11 employees.
View email and phone details for 11
employees at Virofend Therapeutics S.L..
Virofend Therapeutics S.L.'s industry is
Biotechnology Research
Virofend Therapeutics S.L.'s top competitors are
Parque Científico De La Universidad De Salamanca,
Immunostep,
Cidegen,
Lincbiotech,
Neurofix Pharma S.a.,
Globalstart Dynamics S.l.,
Bygens,
300k Solutions,
Neathea,
Raretech.
Virofend Therapeutics S.L.'s categories are Biotechnology Research
Virofend Therapeutics S.L.'s founding year is 2024
